Product news

Share this article:
Shire's Vyvanse, an attention deficit and hyperactivity disorder drug, has received approval for adults. Vyvanse is now available in three additional dosage strengths.

This material may not be published, broadcast, rewritten or redistributed in any form without prior authorization. Your use of this website constitutes acceptance of Haymarket Media's Privacy Policy and Terms & Conditions